Nutra Pharma Corp Stock Short Ratio
Nutra Pharma Corp fundamentals help investors to digest information that contributes to Nutra Pharma's financial success or failures. It also enables traders to predict the movement of Nutra Pink Sheet. The fundamental analysis module provides a way to measure Nutra Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutra Pharma pink sheet.
Nutra |
Nutra Pharma Corp Company Short Ratio Analysis
Nutra Pharma's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Nutra Pharma Corp has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Nutra Fundamentals
| Return On Asset | -1.13 | |||
| Profit Margin | 28.71 % | |||
| Operating Margin | (5.58) % | |||
| Current Valuation | 10.33 M | |||
| Shares Outstanding | 7.6 B | |||
| Shares Owned By Insiders | 1.02 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Sales | 6.13 X | |||
| Revenue | 51.9 K | |||
| Gross Profit | 8.47 K | |||
| EBITDA | (365.66 K) | |||
| Net Income | (769.18 K) | |||
| Cash And Equivalents | 10.45 K | |||
| Total Debt | 517.18 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (878.09 K) | |||
| Target Price | 0.53 | |||
| Beta | 0.25 | |||
| Market Capitalization | 759.68 K | |||
| Total Asset | 301.79 K | |||
| Z Score | -2.7 | |||
| Net Asset | 301.79 K |
About Nutra Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nutra Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.